Dr. François Marceau has been studying bradykinin receptors for over 30 years, their regulation, ligands and functions. Notably, as early as in the 1980s, the regulation of B1 receptor expression by cytokines and immunopathology was highlighted, with work replicated and expanded around the world. He has been part of an international committee on the nomenclature of bradykinin receptors, leading to a review article cited over 800 times, of which he is a co-author (Pharmacol Rev. 2005; 57: 27). More recently, two subjects have caught the attention of the laboratory, i.e. the creation of bifunctional biotechnological ligands for peptide hormone receptors, including those of bradykinin, and the angioedema states, presently the main clinical application of bradykinin. Dr. Marceau has been, and is, regularly invited as a speaker at specialized conferences.
2705, boulevard Laurier
T1-49
Québec, Québec
Canada G1V 4G2
Latest news
Data not available
[Statistical analysis of Price Jones curves for 100 children undergoing antiepileptic treatment]
Journal ArticleC R Seances Soc Biol Fil, 165 (9), 1971.
| Links: 
Active projects
- Séquençage du génome et signature biologique pour le diagnostic de l'héréditaire C1-inh-normal, from 2022-09-01 to 2024-09-30
Recently finished projects
- Mesures des kinines et de leurs métabolites dans le sang des patients atteints de diverses formes d'angio-oedème héréditaire (AOH) , from 2021-08-30 to 2022-03-31